Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
出版年份 2010 全文链接
标题
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
作者
关键词
-
出版物
BMC CANCER
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2010-06-25
DOI
10.1186/1471-2407-10-218
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CD133 antigen expression in ovarian cancer
- (2009) Gabriella Ferrandina et al. BMC CANCER
- Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
- (2009) David Horst et al. CANCER INVESTIGATION
- How powerful is CD133 as a cancer stem cell marker in brain tumors?
- (2009) Jin-Xiang Cheng et al. CANCER TREATMENT REVIEWS
- CD133 and nuclear β-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
- (2009) David Horst et al. EUROPEAN JOURNAL OF CANCER
- Targeting CD133 antigen in cancer
- (2009) Gabriella Ferrandina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer
- (2009) Qi Wang et al. HISTOPATHOLOGY
- The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer
- (2009) David Horst et al. JOURNAL OF PATHOLOGY
- Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
- (2009) Chun-Yan Li et al. Journal of Translational Medicine
- Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
- (2009) Dongho Choi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- CD133 expression is an independent prognostic marker for low survival in colorectal cancer
- (2008) D Horst et al. BRITISH JOURNAL OF CANCER
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
- (2008) S Maeda et al. BRITISH JOURNAL OF CANCER
- Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter
- (2008) Alexei V. Salnikov et al. CANCER LETTERS
- Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
- (2008) Motohiro Kojima et al. CANCER SCIENCE
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma
- (2008) W. Song et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
- (2008) Mingyu Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
- (2008) L. Vermeulen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now